The Perfect Patient Pathway Test Bed evaluation activity continues at full steam as we approach the first anniversary of the start of the programme.
The team comprising CATCH and ScHARR researchers at the University of Sheffield, led by Dr Steven Ariss have already begun the evaluation of two of five Test Bed projects that the team are evaluating between now and 31st March 2018. Each project will introduce combinatorial technology within existing NHS systems and services that aim to improve health outcomes for patients and members of the public.
The first pilot in a community setting introduced a device to support people experiencing diabetes that use insulin to manage their condition. The Insulcheck Digital Device clips on the end of most insulin pens and automatically records the last time the patient injected insulin. This helps avoid double and missed injections adding safety and certainty to injection schedules.
Dr Steven Ariss said: “We are pleased that this device has been well received by Health Professionals as well as patients. We have already learned that even people who need support from family members are able to use the device. One patient told us they are using the device every morning and “it works and it’s great!”. We have also had some great ideas for how to make the device even better for the next part of the project. The pilot has also provided us with invaluable information about how to evaluate quick moving and innovative projects like this.”
The second pilot under way is a device (QTUG) introduced within GP practices to identify people at high risk of falling and offer services already delivered within the NHS in order to help reduce the incidence of falls in the future.
Other projects include technology to support people experiencing mental health issues, using diet apps to manage diabetes, and technology in hospitals to support the frail elderly. In addition, the ScHARR team of researchers will be evaluating the overall Perfect Patient Pathway Test Bed.
You can read the full press release here.